HERON THERAPEUTICS, INC. /DE/·4

Oct 21, 11:23 AM ET

Collard Craig A 4

4 · HERON THERAPEUTICS, INC. /DE/ · Filed Oct 21, 2025

Insider Transaction Report

Form 4
Period: 2025-10-19
Collard Craig A
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-10-19+13,797488,335 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-10-1913,797124,172 total
    Exercise: $0.00Common Stock (13,797 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).

Documents

2 files